MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification

MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification

Çağlar Ünal,1 Tolga Özmen,2,3 Ahmet Serkan İlgün,4 Çetin Ordu,5 Enver Özkurt,6 Naziye Ak,7 Gül Alço,8 Zeynep Erdoğan İyigün,9 Sevgi Kurt,10 Tomris Duymaz,11 Mehmet Alper Öztürk,12 Filiz Elbüken Çelebi,13 Kanay Yararbaş,14 Gürsel Soybir,15 Fatma Akte...

Full description

Bibliographic Details
Main Authors: Ünal Ç, Özmen T, İlgün AS, Ordu Ç, Özkurt E, Ak N, Alço G, Erdoğan İyigün Z, Kurt S, Duymaz T, Öztürk MA, Elbüken Çelebi F, Yararbaş K, Soybir G, Aktepe F, Özmen V
Format: Article
Language:English
Published: Dove Medical Press 2023-09-01
Series:Breast Cancer: Targets and Therapy
Subjects:
breast cancer
mcm-2
oncotype dx recurrence score
tailorx risk categorization
Online Access:https://www.dovepress.com/mcm-2-levels-as-a-potential-biomarker-for-predicting-high-risk-breast--peer-reviewed-fulltext-article-BCTT

Internet

https://www.dovepress.com/mcm-2-levels-as-a-potential-biomarker-for-predicting-high-risk-breast--peer-reviewed-fulltext-article-BCTT

Similar Items